StockData
Perspective Therapeutics, Inc. logo

Perspective Therapeutics, Inc. (CATX) stock

CATXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$0.75−0.03 (-3.85%)

Close on Nov 20, 2026Market cap $86.05MP/E –Yield –

Perspective Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Perspective Therapeutics's price to book ratio was 0.3× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.3× to 3.9×, with a median of 0.9×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20260.3×−0.6
2025Dec 31, 20250.8×+0.2
2024Dec 31, 20240.7×−0.3
2023Dec 29, 20230.9×+0.4
2022Dec 30, 20220.6×−0.3
2021Dec 31, 20210.8×−5.2
2020Dec 31, 20206.1×+0.0
2019Dec 31, 20196.0×+4.2
2018Dec 31, 20181.8×−0.6
2017Dec 29, 20172.4×+0.3
2016Dec 30, 20162.1×−0.5
2015Dec 31, 20152.6×−0.8
2014Dec 31, 20143.4×+0.8
2013Dec 31, 20132.6×−0.7
2012Dec 31, 20123.3×+0.1
2011Dec 30, 20113.2×–

More Perspective Therapeutics figures

See a number that looks wrong?